Literature DB >> 30366654

Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.

William Hsu1, Xinkai Zhou2, Antonia Petruse3, Ngan Chau3, Stephanie Lee-Felker4, Anne Hoyt4, Neil Wenger5, David Elashoff2, Arash Naeim3.   

Abstract

PURPOSE: To analyze women with suspicious findings (assessed as Breast Imaging Reporting and Data System [BI-RADS] 4), examining the value of clinical and imaging predictors in predicting cancer diagnosis. PATIENTS AND METHODS: A set of 2138 examinations (1978 women) given a BI-RADS 4 with matching pathology results were analyzed. Predictors such as patient demographics, clinical risk factors, and imaging-derived features such as BI-RADS assessment and qualitative breast density were considered. Independent predictors of breast cancer were determined by univariate analysis and multivariate logistic regression.
RESULTS: In univariate analysis, age, race, body mass index, age at first live birth, BI-RADS assessment, qualitative breast density, and risk triggers were found to be independent predictors. In multivariate analysis, age, BI-RADS score, breast density, race, presence of a lump, and number of risk triggers were the most predictive. An integrative logistic regression model achieved a performance of 0.84 cross-validated area under the curve. No variable was a constant independent predictor when stratifying the population on the basis of the BI-RADS score.
CONCLUSION: While BI-RADS assessment remains the strongest predictor of breast cancer, the inclusion of clinical risk factors such as age, breast density, presence of a lump, and number of risk triggers derived from guidelines improves the specificity of identifying individuals with imaging descriptors associated with BI-RADS 4A and 4B that are more likely to be diagnosed with breast cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Breast screening; Mammography; Risk factors; Statistical model

Mesh:

Year:  2018        PMID: 30366654     DOI: 10.1016/j.clbc.2018.08.008

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  3 in total

1.  Downgrade BI-RADS 4A Patients Using Nomogram Based on Breast Magnetic Resonance Imaging, Ultrasound, and Mammography.

Authors:  Yamie Xie; Ying Zhu; Weimin Chai; Shaoyun Zong; Shangyan Xu; Weiwei Zhan; Xiaoxiao Zhang
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  A Five-Year Review of the Outcomes of Breast Imaging Reporting and Data System 4 Lesions in Hospital Universiti Sains Malaysia.

Authors:  Karthikeyan Marthay; Maya Mazuwin Yahya; Tengku Ahmad Damitri Al-Astani Tengku Din; Wan Zainira Wan Zain; Juhara Haron; Michael Pak-Kai Wong; Rosenelifaizur Ramely; Wan Muhammad Mokhzani Wan Mokhter; Siti Rahmah Hashim Isa Merican; Mohd Nizam Mohd Hashim
Journal:  Cureus       Date:  2022-03-01

3.  Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A.

Authors:  Sihua Niu; Jianhua Huang; Jia Li; Xueling Liu; Dan Wang; Ruifang Zhang; Yingyan Wang; Huiming Shen; Min Qi; Yi Xiao; Mengyao Guan; Haiyan Liu; Diancheng Li; Feifei Liu; Xiuming Wang; Yu Xiong; Siqi Gao; Xue Wang; Jiaan Zhu
Journal:  BMC Cancer       Date:  2020-10-02       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.